Annual Drug Patent Expirations for TAVALISSE
Tavalisse is a drug marketed by Rigel Pharms Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.
This drug has one hundred and three patent family members in forty-five countries.
The generic ingredient in TAVALISSE is fostamatinib disodium. One supplier is listed for this compound. Additional details are available on the fostamatinib disodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com